Quantcast

PENNSYLVANIA RECORD

Saturday, November 2, 2024

Case activity for Amy Taklif vs The Cooper Companies Inc. on Sept. 29

Filings
Shutterstock 146730020

shutterstock.com

The U.S. District Court for the Eastern District of Pennsylvania reported the following activities in the suit brought by Amy Taklif against Coopersurgical Inc., Duramed Pharmaceuticals Inc. a Division of Barr Pharmaceuticals, INC. D B a Teva Women's Health, INC., Teva Pharmaceuticals USA Inc., Teva Women's Health Inc. Individually, and, Teva Women's Health LLC F K a Teva Women's Health, Inc., Teva Women's Health LLC, Individually and and The Cooper Companies Inc. on Sept. 29.

'Notice Of Removal By Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Teva Women's Health, Inc. Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc., Coopersurgical, Inc., Teva Women's Health, Llc F/k/a Teva Women's Health, Inc., The Cooper Companies, Inc., Teva Pharmaceuticals Usa, Inc (filing Fee $ 400 Receipt Number 0313-14599225), Philadelphia Court Of Common Pleas, Case Number 20203066, Filed By Duramed Pharmaceuticals, Inc. A Division Of Barr Pharmaceuticals, Inc. D/b/a Teva Women's Health, Inc., Teva Women's Health, Llc, Individually And As Successor In Interest To Teva Women's Health, Inc., Teva Women's Health, Inc. Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc., Coopersurgical, Inc., Teva Women's Health, Llc F/k/a Teva Women's Health, Inc., The Cooper Companies, Inc., Teva Pharmaceuticals Usa, Inc.(rubenstein, Brian) Modified On 9/29/2020 (tjd).'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Vanguard Group, Inc. By The Cooper Companies, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including The Cooper Companies, Inc. By Coopersurgical, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Pharmaceuticals Usa, Inc.(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health, Inc. Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Disclosure Statement Form Pursuant To Frcp 7.1 Including Teva Pharmaceutical Industries Ltd. By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Inc. Individually, And As Successor In Interest To, Duramed Pharmaceuticals, Inc., A Divison Of Barr Pharmaceuticals, Inc..(rubenstein, Brian)'

'Answer To Complaint By Teva Women's Health, Llc F/k/A Teva Women's Health, Inc..(rubenstein, Brian)'

Case number 2:20-cv-04768-HB was filed in the U.S. District Court for the Eastern District of Pennsylvania on Sept. 29.

More News